Facebook
Twitter
Telegram
Report an ErrorNabriva Therapeutics plc Cash Flow 2011-2024 | NBRV
Annual Cash Flow Nabriva Therapeutics plc
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-36.7 M | -59.6 M | -71.3 M | -71.9 M | -72.7 M | -69.3 M | -48.3 M | -21.9 M | - | - | - | - |
Depreciation & Amortization |
217 K | 356 K | 417 K | 396 K | 510 K | 432 K | 233 K | 153 K | 166 K | - | - | - |
Accounts Payables |
5.43 M | 4.37 M | 2.89 M | 4.67 M | 3.3 M | 5.14 M | 2.55 M | - | - | - | - | - |
Accounts Receivables |
3.21 M | 8.78 M | 3.91 M | 2.74 M | - | - | - | - | - | - | - | - |
Total Inventories |
9.68 M | 14.5 M | 5.82 M | 682 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Nabriva Therapeutics plc
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-5.62 M | - | -35.1 M | - | -15.9 M | - | -53.4 M | - | -21.6 M | - | -58 M | -45.4 M | -28.1 M | - | -56.4 M | -41.7 M | -20.6 M | - | -50.5 M | -33.4 M | -16.3 M | - | -45.3 M | -30.2 M | -14.7 M | - | -37.7 M | -25.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
21 K | - | 192 K | - | 78 K | - | 270 K | - | 99 K | - | 315 K | 209 K | 103 K | - | 162 K | 245 K | 125 K | - | 391 K | 262 K | 133 K | - | 295 K | 149 K | 76 K | - | 172 K | 99 K | 45 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
6.98 M | 5.43 M | 3.9 M | - | 1.58 M | 4.37 M | 1.48 M | 1.58 M | 3.64 M | 2.89 M | 2.89 M | 2.89 M | 2.89 M | 4.67 M | 4.67 M | 4.67 M | 4.67 M | 3.3 M | 3.3 M | 3.3 M | 3.3 M | 5.14 M | 5.14 M | 5.14 M | 5.14 M | 2.55 M | 2.55 M | 2.55 M | 2.55 M | 2.93 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
10.5 M | 6.74 M | 12.4 M | - | 11 M | 12.8 M | 15 M | 11.6 M | 4.21 M | 56 K | 3.91 M | 3.91 M | 3.91 M | 2.74 M | 2.74 M | 2.74 M | 2.74 M | 3.87 M | 3.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
9.03 M | 9.68 M | 17.3 M | - | 15.6 M | 14.5 M | 15.6 M | 10.1 M | 8.97 M | 5.82 M | 5.82 M | 5.82 M | 5.82 M | 682 K | 682 K | 682 K | 682 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency